$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

$hdsn Overview Financials Valuation SEC Filings Company Website

2012 Q3 Form 10-Q Financial Statement

#000114420412042349 Filed on August 01, 2012

Income Statement

Concept	2012 Q3	2012 Q2	2011 Q4
Revenue	$14.47M	$22.25M	$3.860M
YoY Change	21.19%	51.24%	-6.76%
Cost Of Revenue	$9.110M	$12.01M	$3.050M
YoY Change	-12.99%	0.07%	9.32%
Gross Profit	$5.370M	$10.24M	$810.0K
YoY Change	265.31%	278.17%	-40.44%
Gross Profit Margin	37.11%	46.01%	20.98%
Selling, General & Admin	$1.650M	$1.768M	$1.800M
YoY Change	13.01%	50.08%	-4.26%
% of Gross Profit	30.73%	17.27%	222.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$160.0K	$130.0K	$120.0K
YoY Change	23.08%	8.33%	-7.69%
% of Gross Profit	2.98%	1.27%	14.81%
Operating Expenses	$1.650M	$1.768M	$1.810M
YoY Change	13.01%	50.08%	-3.21%
Operating Profit	$3.720M	$8.469M	-$1.000M
YoY Change	37100.0%	453.89%	96.08%
Interest Expense	-$170.0K	$187.0K	-$170.0K
YoY Change	-10.53%	-31.75%	-45.16%
% of Operating Profit	-4.57%	2.21%
Other Income/Expense, Net		-$186.0K
YoY Change		-31.11%
Pretax Income	$3.540M	$8.283M	-$1.170M
YoY Change	-2066.67%	557.9%	42.68%
Income Tax	$1.350M	$3.148M	-$440.0K
% Of Pretax Income	38.14%	38.01%
Net Earnings	$2.190M	$5.135M	-$720.0K
YoY Change	-2090.91%	557.49%	28.57%
Net Earnings / Revenue	15.13%	23.08%	-18.65%
Basic Earnings Per Share		$0.22
Diluted Earnings Per Share	$82.42K	$0.20	-$30.28K
COMMON SHARES
Basic Shares Outstanding	23.87M shares	23.84M shares
Diluted Shares Outstanding		26.18M shares

Balance Sheet

Concept	2012 Q3	2012 Q2	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.400M	$4.000M	$4.000M
YoY Change	-34.62%	37.93%	2.56%
Cash & Equivalents	$3.400M	$4.008M	$3.958M
Short-Term Investments
Other Short-Term Assets	$900.0K	$3.800M	$600.0K
YoY Change	-50.0%	660.0%	50.0%
Inventory	$34.70M	$33.14M	$17.73M
Prepaid Expenses
Receivables	$5.100M	$8.186M	$2.453M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$44.20M	$49.12M	$24.76M
YoY Change	104.63%	87.47%	1.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.700M	$3.727M	$3.441M
YoY Change	23.33%	28.52%	14.7%
Goodwill
YoY Change
Intangibles		$92.00K	$89.00K
YoY Change
Long-Term Investments			$0.00
YoY Change
Other Assets	$400.0K	$214.0K	$79.00K
YoY Change	-85.19%	-91.77%	-97.86%
Total Long-Term Assets	$4.100M	$4.033M	$6.695M
YoY Change	-29.31%	-27.98%	-1.54%
TOTAL ASSETS
Total Short-Term Assets	$44.20M	$49.12M	$24.76M
Total Long-Term Assets	$4.100M	$4.033M	$6.695M
Total Assets	$48.30M	$53.15M	$31.45M
YoY Change	76.28%	67.14%	1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.800M	$14.50M	$5.200M
YoY Change	15.15%	400.0%	-18.75%
Accrued Expenses	$800.0K	$700.0K	$700.0K
YoY Change	100.0%	133.33%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.500M	$5.400M	$6.400M
YoY Change	123.68%	-37.93%	28.0%
Total Short-Term Liabilities	$14.30M	$21.29M	$12.29M
YoY Change	90.67%	80.41%	1.58%
LONG-TERM LIABILITIES
Long-Term Debt	$5.000M	$5.064M	$121.0K
YoY Change	2400.0%	4964.0%	-87.9%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$5.000M	$5.064M	$121.0K
YoY Change	2400.0%	4964.0%	-87.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.30M	$21.29M	$12.29M
Total Long-Term Liabilities	$5.000M	$5.064M	$121.0K
Total Liabilities	$19.20M	$26.35M	$12.41M
YoY Change	149.35%	119.6%	-5.25%
SHAREHOLDERS EQUITY
Retained Earnings		-$16.43M	-$24.07M
YoY Change
Common Stock		$239.0K	$238.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$29.10M	$26.80M	$19.04M
YoY Change
Total Liabilities & Shareholders Equity	$48.30M	$53.15M	$31.45M
YoY Change	76.28%	67.14%	1.13%

Cashflow Statement

Concept	2012 Q3	2012 Q2	2011 Q4
OPERATING ACTIVITIES
Net Income	$2.190M	$5.135M	-$720.0K
YoY Change	-2090.91%	557.49%	28.57%
Depreciation, Depletion And Amortization	$160.0K	$130.0K	$120.0K
YoY Change	23.08%	8.33%	-7.69%
Cash From Operating Activities	-$3.520M	-$1.410M	-$3.220M
YoY Change	-147.7%	-171.57%	544.0%
INVESTING ACTIVITIES
Capital Expenditures	-$110.0K	-$380.0K	-$530.0K
YoY Change	-56.0%	375.0%	51.43%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$100.0K	-$390.0K	-$530.0K
YoY Change	-60.0%	387.5%	51.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.060M	5.650M	2.520M
YoY Change	-162.83%	-310.04%	265.22%
NET CHANGE
Cash From Operating Activities	-3.520M	-1.410M	-3.220M
Cash From Investing Activities	-100.0K	-390.0K	-530.0K
Cash From Financing Activities	3.060M	5.650M	2.520M
Net Change In Cash	-560.0K	3.850M	-1.230M
YoY Change	-124.78%	-581.25%	668.75%
FREE CASH FLOW
Cash From Operating Activities	-$3.520M	-$1.410M	-$3.220M
Capital Expenditures	-$110.0K	-$380.0K	-$530.0K
Free Cash Flow	-$3.410M	-$1.030M	-$2.690M
YoY Change	-144.69%	-150.24%	1693.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3786000
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	214000
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	26798000
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	27000000
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23873392	shares
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2921000
CY2012Q2	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2667000	shares
CY2012Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	701000
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	658000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5500000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9771000
CY2012Q2	hdsn	Ownership Interest In Joint Venture OwnershipInterestInJointVenture	0.40	pure
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.23
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3926000
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3727000
CY2012Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42984000
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5064000
CY2012Q2	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumber	3385880	shares
CY2012Q2	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice	1.21
CY2012Q2	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Cancellations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriodWeightedAverageExercisePrice	1.10
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23873392	shares
CY2012Q2	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	9127000
CY2012Q2	us-gaap	Liabilities Liabilities	26352000
CY2012Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	245000
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	0
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16425000
CY2012Q2	us-gaap	Assets Assets	53150000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.21
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8186000
CY2012Q2	us-gaap	Inventory Net InventoryNet	33137000
CY2012Q2	us-gaap	Debt Current DebtCurrent	5446000
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53150000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4008000
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23873392	shares
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	92000
CY2012Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14483000
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21288000
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	201000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3385880	shares
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	239000
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Assets Current AssetsCurrent	49117000
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3411943	shares
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	611000
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79000
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	19039000
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	700
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	703000
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23783106	shares
CY2011Q4	us-gaap	Liabilities Liabilities	12412000
CY2011Q4	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Cancellations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationsInPeriodWeightedAverageExercisePrice	2.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025	pure
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3086000
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24068000
CY2011Q4	us-gaap	Assets Assets	31451000
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2453000
CY2011Q4	us-gaap	Inventory Net InventoryNet	17734000
CY2011Q4	us-gaap	Debt Current DebtCurrent	6361000
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31451000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3958000
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23783106	shares
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	89000
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5227000
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12291000
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3435443	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	238000
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Assets Current AssetsCurrent	24756000
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3441000
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42869000
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	121000
	us-gaap	Operating Income Loss OperatingIncomeLoss	3519000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	26499000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	482000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0
	us-gaap	Share Based Compensation ShareBasedCompensation	9000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3899000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22121000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	90000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	254000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3550000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-170000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	29000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	149000
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	3287000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-505000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1005000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1792000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	131000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25082275	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7184000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3014000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1098000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2715000
	us-gaap	Operating Expenses OperatingExpenses	2890000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.56	pure
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23780606	shares
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4397000
	us-gaap	Revenues Revenues	28530000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2031000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9000
	us-gaap	Gross Profit GrossProfit	6409000
	us-gaap	Interest Paid InterestPaid	498000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	21000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1124000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1324375	shares
	us-gaap	Net Income Loss NetIncomeLoss	1869000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1145000
	us-gaap	Interest Expense InterestExpense	517000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0
	hdsn	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	6000
	hdsn	Entity Wide Disclosure Description Of Concentrations Of Revenue From External Customers EntityWideDisclosureDescriptionOfConcentrationsOfRevenueFromExternalCustomers	No one customer accounted for 10% or more of the Company's revenues.
	hdsn	Customers Accounting For Ten Percent Or More Of Net Revenue CustomersAccountingForTenPercentOrMoreOfNetRevenue	0	Customer
	dei	Trading Symbol TradingSymbol	HDSN
	dei	Entity Registrant Name EntityRegistrantName	HUDSON TECHNOLOGIES INC /NY
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1991-01-11
	dei	Entity Central Index Key EntityCentralIndexKey	0000925528
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to domestic rate loans, the sum of (i) a rate per annum equal to the higher of (1) the base commercial lending rate of PNC, (2) the federal funds open rate plus .5% and (3) the daily LIBOR plus 1%, plus (ii) .5% and (B) with respect to Eurodollar rate loans, the sum of the Eurodollar rate plus 2.25%.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	95000
	us-gaap	Operating Income Loss OperatingIncomeLoss	12687000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	34776000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	116000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2071000
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	3000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y9M18D
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9548000
	us-gaap	Share Based Compensation ShareBasedCompensation	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9211000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	41250	shares
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20900000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Credit risk</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivables are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p> <p style="TEXT-ALIGN: left; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the six months ended June 30, 2012, three customers each accounted for 10% or more of the Company’s revenues and in the aggregate these three customers accounted for 40% of the Company’s revenues. For the six months ended June 30, 2011, no one customer accounted for 10% or more of the Company’s revenues.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have an adverse effect on the Company's future financial position and results of operations.</p> </div>
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	264000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3537000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-556000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	899000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.66
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	533000
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1711000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	50000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2164000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4387000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3307000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26149740	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5734000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12330000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1354000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4143000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8313	shares
	us-gaap	Operating Expenses OperatingExpenses	3518000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23813776	shares
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2015-06-22
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15403000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M18D
	us-gaap	Revenues Revenues	37105000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2329000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense
	us-gaap	Gross Profit GrossProfit	16205000
	us-gaap	Interest Paid InterestPaid	358000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3086000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
	us-gaap	Net Income Loss NetIncomeLoss	7644000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-357000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4686000
	us-gaap	Use Of Estimates UseOfEstimates	<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"> Estimates and risks</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p> <p style="TEXT-ALIGN: justify; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Several of the Company's accounting policies involve significant judgments, uncertainties and estimations. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="COLOR: black">The Company participates in an industry that is highly regulated, changes in which could affect operating results. Currently the Company purchases virgin, hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants.</font> Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants and which imposed limitations on the importation of certain virgin HCFC refrigerants. Additionally, effective January 1, 2010, the Act further limited the production of virgin HCFC refrigerants and additional federal regulations were enacted which imposed further limitation and a phase down on the use, production and importation of virgin HCFC refrigerants. As a result of litigation, the federal regulations implementing the January 2010 phase down schedule have been vacated. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In January 2012, the Environmental Protection Agency (“EPA”) published a proposed rule, which would further reduce the production of HCFC refrigerants when compared to the reductions established in the January 1, 2010 published rule. The reductions set forth in the proposed rule range from 11 to 47 percent from the levels established in the prior rule, for calendar years 2012, 2013, and 2014. The proposed rule is not final and in the interim the EPA has provided allowance holders with no action assurance letters, which permits allowance holders to import or produce up to an amount that equals 55% of the amount each allowance holder could import or produce in 2011.</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="COLOR: black">To the extent that the Company is unable to</font> source sufficient quantities of refrigerants <font style="COLOR: black">or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants, the Company could realize reductions in refrigerant processing and possible loss of revenues, which would have a material adverse affect on operating results.</font></p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which would have a material adverse effect on operating results and its financial position.</p> </div>
	us-gaap	Interest Expense InterestExpense	358000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	701000
	hdsn	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	0
	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue	0
	hdsn	Entity Wide Disclosure Description Of Concentrations Of Revenue From External Customers EntityWideDisclosureDescriptionOfConcentrationsOfRevenueFromExternalCustomers	Three customers each accounted for 10% or more of the Company's revenues and in the aggregate these three customers accounted for 40% of the Company's revenues
	hdsn	Customers Accounting For Ten Percent Or More Of Net Revenue CustomersAccountingForTenPercentOrMoreOfNetRevenue	3	Customer
	hdsn	Cash Equivalents Maturity Period CashEquivalentsMaturityPeriod	P90D
	hdsn	Entity Wide Revenue Major Customer Percentage Of Revenue EntityWideRevenueMajorCustomerPercentageOfRevenue	0.40	pure
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2500	shares
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.12
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	49000	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	75000	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.31
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1529000
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2011Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12005000
CY2011Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000
CY2011Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	723000
CY2011Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24989119	shares
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1259000
CY2011Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	455000
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	1178000
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23780606	shares
CY2011Q2	us-gaap	Revenues Revenues	14712000
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000
CY2011Q2	us-gaap	Gross Profit GrossProfit	2707000
CY2011Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1471875	shares
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	781000
CY2011Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-270000
CY2011Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	478000
CY2011Q2	us-gaap	Interest Expense InterestExpense	274000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	8469000
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2012Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12014000
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1095000
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26177960	shares
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8283000
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	673000
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	1768000
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23841996	shares
CY2012Q2	us-gaap	Revenues Revenues	22251000
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense
CY2012Q2	us-gaap	Gross Profit GrossProfit	10237000
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	5135000
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-186000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3148000
CY2012Q2	us-gaap	Interest Expense InterestExpense	187000

Files In Submission

Name	View Source	Status
0001144204-12-042349-index-headers.html	Edgar Link	pending
0001144204-12-042349-index.html	Edgar Link	pending
0001144204-12-042349.txt	Edgar Link	pending
0001144204-12-042349-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
hdsn-20120630.xml	Edgar Link	completed
hdsn-20120630.xsd	Edgar Link	pending
hdsn-20120630_cal.xml	Edgar Link	unprocessable
hdsn-20120630_def.xml	Edgar Link	unprocessable
hdsn-20120630_lab.xml	Edgar Link	unprocessable
hdsn-20120630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v318346_10q.htm	Edgar Link	pending
v318346_ex31-1.htm	Edgar Link	pending
v318346_ex31-2.htm	Edgar Link	pending
v318346_ex32-1.htm	Edgar Link	pending
v318346_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2012 Q3 Form 10-Q Financial Statement

#000114420412042349 Filed on August 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2012 Q3 Form 10-Q Financial Statement

#000114420412042349 Filed on August 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn